Top Page
Chemring
(LSE:CHG)
Chemring (CHG) vs. iShares MSCI United Kingdom ETF (EWC)
Chemring Business Overview & Revenue Model
Chemring Earnings Call Summary
Chemring Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 510.40M | 472.60M | 442.80M | 393.30M | 402.50M |
| Gross Profit | 510.40M | 472.60M | 442.80M | 393.30M | 402.50M |
| EBITDA | 82.70M | 67.10M | 71.20M | 75.50M | 75.10M |
| Net Income | 39.50M | 5.40M | 47.40M | 41.50M | 34.70M |
Balance Sheet | |||||
| Total Assets | 692.10M | 596.40M | 620.10M | 531.50M | 541.40M |
| Cash, Cash Equivalents and Short-Term Investments | 45.00M | 6.40M | 19.80M | 5.80M | 14.70M |
| Total Debt | 97.70M | 20.70M | 26.90M | 32.30M | 62.80M |
| Total Liabilities | 335.80M | 217.90M | 202.00M | 178.70M | 211.80M |
| Stockholders Equity | 356.30M | 378.50M | 418.10M | 352.80M | 329.60M |
Cash Flow | |||||
| Free Cash Flow | 11.40M | 31.70M | 46.00M | 45.50M | 35.10M |
| Operating Cash Flow | 81.00M | 65.90M | 80.50M | 75.70M | 75.90M |
| Investing Cash Flow | -47.60M | -39.40M | -30.50M | -34.90M | -25.40M |
| Financing Cash Flow | -37.30M | -40.20M | -35.80M | -50.40M | -32.10M |
Chemring Technical Analysis
Chemring Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | £1.45B | 37.50 | 11.62% | 1.46% | 8.00% | 674.47% | |
64 Neutral | $10.73B | 15.74 | 7.64% | 2.01% | 2.76% | -15.10% | |
| ― | $69.26B | 28.36 | 17.59% | 2.94% | ― | ― | |
77 Outperform | £2.18B | 45.37 | 5.21% | 1.58% | 0.84% | -62.73% | |
66 Neutral | £606.34M | 28.98 | 14.40% | 1.31% | 33.33% | 19.01% | |
65 Neutral | £572.67M | 113.18 | 4.18% | 0.97% | 14.69% | ― | |
56 Neutral | £2.58B | 17.97 | -23.92% | 1.85% | 1.02% | -240.44% |
Chemring Corporate Events
Chemring Group PLC has applied for a blocklisting of 445,049 ordinary shares to be admitted to the London Stock Exchange. This move, linked to the exercise of employee share options under the Chemring Group 2018 UK Sharesave Plan, is expected to enhance the company’s market presence and provide liquidity options for its stakeholders.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £670.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC announced its current capital structure, consisting of 272,208,518 ordinary shares with voting rights and 62,500 cumulative preference shares without voting rights, except in specific situations. This information is crucial for shareholders to determine their reporting obligations under the FCA’s Disclosure and Transparency Rules, potentially impacting shareholder engagement and compliance requirements.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £670.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC has announced the acquisition of Landguard Nexus Limited and its subsidiaries, aiming to enhance the growth of its Roke business. This acquisition, valued at up to £20 million, will integrate Landguard’s software-defined radio systems and security products into Chemring’s portfolio, strengthening its position in the defense, national security, and law enforcement markets. The acquisition is expected to bring operational synergies and expand Chemring’s international sales pipeline, while being marginally earnings enhancing by 2026.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £670.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC has announced that its joint feasibility study with the Norwegian Government, aimed at assessing a new production facility for military explosives, will progress to its second phase. This development underscores the critical need to expand capacity in the European defense industrial base and aligns with Chemring’s strategy of growth through organic investment and acquisitions in key defense and national security markets.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £670.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC announced that following the exercise or lapse of all options under its 2018 UK Sharesave Plan, there are no remaining 1p Ordinary Shares to be issued from the initial block listing of 579,888 shares. This update signifies the completion of the share issuance process related to the plan, potentially impacting the company’s share distribution strategy and stakeholder equity interests.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £670.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC, a company involved in the defense and security industry, has announced the repurchase of 59,852 of its ordinary shares at a weighted average price of 490.8067 pence per share. This transaction is part of a buyback program initiated earlier in the year, with the intent to cancel the purchased shares, potentially enhancing shareholder value and optimizing the capital structure.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £460.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC announced its interim results for the six months ending April 30, 2025, reporting a record order book and order intake, with revenue growth driven by strong performance in its Countermeasures & Energetics segment. The company’s financial performance aligns with board expectations, maintaining strong long-term growth prospects due to robust customer demand and a high-quality pipeline of growth opportunities. Despite an increase in net debt due to capital expenditure, Chemring remains well-positioned to capitalize on increased defense spending, particularly across NATO, aiming to achieve £1bn in revenue by 2030.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £460.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.
Chemring Group PLC has announced the appointment of Pete Raby as an independent non-executive director, effective from September 1, 2025. Raby, who is currently the CEO of Morgan Advanced Materials plc, brings a wealth of experience in global technology and manufacturing operations, having led significant transformations at Morgan. His appointment is expected to contribute to Chemring’s continued development and performance, enhancing its strategic positioning in the industry.
The most recent analyst rating on (GB:CHG) stock is a Buy with a £460.00 price target. To see the full list of analyst forecasts on Chemring stock, see the GB:CHG Stock Forecast page.